Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinli Sun

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Immunity|April 14, 2021
Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93Jinling Huang, Hae-Youn Lee, Xiaohong Zhao, et al.
The Journal of Experimental Medicine|January 23, 2023
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infectionQinli Sun, Xiaohong Zhao, Ruifeng Li, et al.
Cell Reports|June 1, 2024
NR4A1 transcriptionally regulates the differentiation of stem-like CD8<sup>+</sup> T cells in the tumor microenvironmentJing Hao, Ruifeng Li, Xiaohong Zhao, et al.
Nature|August 13, 2025
Expanding the cytokine receptor alphabet reprograms T cells into diverse statesYang Zhao, Masato Ogishi, Aastha Pal, et al.
Nature|March 12, 2026
Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonistQinli Sun, Alison K Barrett, Masato Ogishi, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Selective Immune Silencing by Targeted TGF-β AgonistsQinli Sun, Masato Ogishi, Hua Jiang, et al.
The Journal of Experimental Medicine|February 6, 2026
Zbtb32 promotes CD8+ T cell differentiation and function in cancerBirui Pan, Qinli Sun, Ruifeng Li, et al.
Science (New York, N.Y.)|November 13, 2025
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunityBowen Xie, Bowen Yuan, Xiaohong Zhao, et al.
Science Immunology|October 20, 2023
BCL6 promotes a stem-like CD8<sup>+</sup> T cell program in cancer via antagonizing BLIMP1Qinli Sun, Dongli Cai, Dingfeng Liu, et al.
Cancer Cell|January 31, 2025
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancerXinyi Guo, Hu Nie, Wenwen Zhang, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Immunity|April 14, 2021
Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93Jinling Huang, Hae-Youn Lee, Xiaohong Zhao, et al.
The Journal of Experimental Medicine|January 23, 2023
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infectionQinli Sun, Xiaohong Zhao, Ruifeng Li, et al.
Cell Reports|June 1, 2024
NR4A1 transcriptionally regulates the differentiation of stem-like CD8<sup>+</sup> T cells in the tumor microenvironmentJing Hao, Ruifeng Li, Xiaohong Zhao, et al.
Nature|August 13, 2025
Expanding the cytokine receptor alphabet reprograms T cells into diverse statesYang Zhao, Masato Ogishi, Aastha Pal, et al.
Nature|March 12, 2026
Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonistQinli Sun, Alison K Barrett, Masato Ogishi, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Selective Immune Silencing by Targeted TGF-β AgonistsQinli Sun, Masato Ogishi, Hua Jiang, et al.
The Journal of Experimental Medicine|February 6, 2026
Zbtb32 promotes CD8+ T cell differentiation and function in cancerBirui Pan, Qinli Sun, Ruifeng Li, et al.
Science (New York, N.Y.)|November 13, 2025
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunityBowen Xie, Bowen Yuan, Xiaohong Zhao, et al.
Science Immunology|October 20, 2023
BCL6 promotes a stem-like CD8<sup>+</sup> T cell program in cancer via antagonizing BLIMP1Qinli Sun, Dongli Cai, Dingfeng Liu, et al.
Cancer Cell|January 31, 2025
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancerXinyi Guo, Hu Nie, Wenwen Zhang, et al.
Pageof 5